Chemical compound
Pharmaceutical compound
BU-LAD, also known as 6-butyl-6-nor-LSD or 6-butyl-6-nor-lysergic acid diethylamide, is a psychedelic drug and analogue of lysergic acid diethylamide (LSD) first described by David E. Nichols and colleagues in the 1980s.[2][3]
Use and effects
According to Alexander Shulgin in his book TiHKAL (Tryptamines I Have Known and Loved), BU-LAD is a psychedelic drug similar to LSD, but is significantly less potent than LSD, with a dose of 500 μg orally producing only mild effects.[1]
Interactions
Chemistry
Analogues
Analogues of BU-LAD include LSD, ETH-LAD, PRO-LAD, AL-LAD, PARGY-LAD, and MAL-LAD, among others.
See also
References
- ^ a b Shulgin, Alexander; Shulgin, Ann (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252.
- ^ Nichols DE, Oberlender R, McKenna DJ (1991). “Stereochemical Aspects of Hallucinogenesis”. In Watson RR (ed.). Biochemistry and Physiology of Substance Abuse. Vol. 3. Boca Raton, Fla.: CRC Press. pp. 1–39. ISBN 978-0-8493-4463-3. OCLC 26748320.
TABLE 1 Effects of N-(6)-Alkyl Subtituents on LSD-Like Behavior and Serotonin Receptor Affinity in Rats […]
- ^ Hoffman AJ, Nichols DE (September 1985). “Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives”. Journal of Medicinal Chemistry. 28 (9): 1252–5. doi:10.1021/jm00147a022. PMID 4032428.
External links
| Ergolines (incl. lysergines) |
|
|---|---|
| Clavines (6,8-dimethylergolines) | |
| Lysergamides (lysergic acid amides) |
|
| Ergopeptines (peptide ergolines) |
|
| Partial ergolines |
|
| Related compounds | |
| Natural sources |
|